Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06011720 · ClinicalTrials.gov registry record
Transitions of Care for Stroke Patients
A clinical trial of Stroke and Ischemic Stroke, sponsored by Kiwon Lee MD.
- Recruiting
- Registry status
- 3,000
- Enrollment target
- 1
- Study location
NCT06011720: Recruiting study of Stroke and Ischemic Stroke, sponsored by Kiwon Lee MD.
NCT06011720 is a study of Stroke and Ischemic Stroke that is actively recruiting participants, run by Kiwon Lee MD. The registered enrollment target is 3,000 participants, below the 12,010-participant average among 454 other Stroke trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06011720, a study of Stroke and Ischemic Stroke, is actively recruiting participants, sponsored by Kiwon Lee MD.
- RECRUITING
- Registry status
- 3,000 participants
- Enrollment target
- 1
- Study location
Study Summary
For stroke patients, early initiation of therapy typically yields the best functional outcomes. Rehabilitation of stroke patients immediately after hospitalization minimizes deleterious effects of immobility and facilitates restoration of function. The investigators are testing if coordinated efforts between the medical and rehabilitation disciplines may improve stroke patient's functional recovery and subsequent follow-ups after discharge.
Primary Outcome
We standardized the placement of early physiatry consults during patient admission. We will determine the effect this has on overall acute care length of stay in ischemic and hemorrhagic stroke patients.
Conditions Studied
Interventions
- OTHER Improved transition of care.
Study Locations (1)
New Jersey
- Rutgers-RWJMS Department of Neurology - New Brunswick
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 2019-05-01 |
| Est. Completion | 2027-07-01 |
What NCT06011720 shows while recruiting
NCT06011720 is an observational study that tracks outcomes without assigning an intervention. Its 3,000 participants enrollment target places it among the larger protocols in the corpus, below the 12,010-participant average among 454 other Stroke trials with a reported enrollment target (75% lower).
The record links to 3 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which Improved transition of care. is the first listed.
NCT06011720 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT06011720 about?
NCT06011720 is a clinical study titled "Transitions of Care for Stroke Patients". For stroke patients, early initiation of therapy typically yields the best functional outcomes. Rehabilitation of stroke patients immediately after hospitalization minimizes deleterious effects of immobility and facilitates restoration of function. The investigators are testing if coordinated effort...
What is the current status of trial NCT06011720?
This trial is currently recruiting. The enrollment target is 3,000 participants. The study started on 2019-05-01. Estimated completion is 2027-07-01.
What conditions does trial NCT06011720 study?
This clinical trial studies the following conditions: Stroke, Ischemic Stroke, Intracerebral Hemorrhage.
What interventions are being tested in trial NCT06011720?
The interventions under investigation include: Improved transition of care. (OTHER).
Who is sponsoring clinical trial NCT06011720?
This trial is sponsored by Kiwon Lee MD, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06011720 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06011720's enrollment target sits among peer trials
3,000 22nd of 454 higher than 432 of 454 other Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The SLEEPR Study: SLEep Effects on Post-stroke Rehabilitation
RECRUITING
-
Tracking a Tactile Signal Along the Nervous System
RECRUITING · NA
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Genetic and Environmental Risk Factors for Hemorrhagic Stroke
RECRUITING
-
Strategy Training for Individuals With Unilateral Neglect
RECRUITING · NA
-
Weight Loss and ExeRcise
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004847 · 3,000 participants · Phase 1
Diagnosis of Pheochromocytoma
- NCT00478712 · 3,000 participants
Hirschsprung Disease Genetic Study
- NCT00579566 · 3,000 participants
Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
- NCT00816114 · 3,000 participants
Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI